Matt Bottomley analyst

Currently out of the existing stock ratings of Matt Bottomley, 20 are a HOLD (41.67%), 17 are a BUY (35.42%), 11 are a SELL (22.92%).

Matt Bottomley

Work Performance Price Targets & Ratings Chart

Analyst Matt Bottomley, carries an average stock price target met ratio of 52.08% that have a potential upside of 42.44% achieved within 311 days. Previously, Matt Bottomley worked at MIZUHO.

Matt Bottomley’s has documented 72 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ACB, Aurora Cannabis at 08-Aug-2024.

Wall Street Analyst Matt Bottomley

Analyst best performing recommendations are on APHA (APHRIA).
The best stock recommendation documented was for APHA (APHRIA) at 4/13/2021. The price target of $18 was fulfilled within 17 days with a profit of $3.15 (21.21%) receiving and performance score of 12.48.

Average potential price target upside

ACB Aurora Cannabis APHA Aphria CGC Canopy Growth Corp CURLF Curaleaf Holdings HEXO Hexo Corp TLRY Tilray CRON Cronos Group AYRWF AYR Strategies GTBIF Green Thumb Industries CCHWF Columbia Care MMNFF Medmen Enterprises VRNOF Verano Holdings Corp HR Healthcare Realty Trust

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Dec-2024

$9

$5.74 (176.07%)

1 years 3 months 24 days ago
(11-Dec-2024)

0/1 (0%)

$4.66 (107.37%)

Buy Since 08-Aug-2024

1 years 7 months 27 days ago
(08-Aug-2024)

1/2 (50%)

$-4.52 (-84.96%)

487

Hold Since 27-Jun-2024

$3

1 years 9 months 8 days ago
(27-Jun-2024)

4/4 (100%)

$-10 (-76.92%)

544

Hold Since 23-Sep-2020

$2

$-1.44 (-41.86%)

3 years 3 months 7 days ago
(28-Dec-2022)

2/3 (66.67%)

$-6.47 (-76.39%)

718

Hold

3 years 10 months 19 days ago
(16-May-2022)

4/7 (57.14%)

$6.37 (31.42%)

9

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Matt Bottomley?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?